Astera Labs (NASDAQ:ALAB) Trading Up 2.1% - Still a Buy?

Key Points

• Astera Labs shares rose 2.1% in Wednesday trading, touching an intraday high of $326.97 as the stock continued to trade near recent highs.
• The company’s latest earnings were strong, with EPS of $0.61 topping estimates and revenue up 93.5% year over year; management also issued Q2 guidance calling for continued growth.
• Sentiment is mixed despite the rally: several analysts remain bullish, but Northland Securities downgraded the stock and recent insider selling, including a large COO sale, may temper short-term enthusiasm.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) traded up 2.1% on Wednesday . The stock traded as high as $326.97 and last traded at $325.33. 5,117,810 shares traded hands during mid-day trading, a decline of 8% from the average session volume of 5,543,899 shares. The stock had previously closed at $318.72.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs announced it will host press conferences, live demos, and technical talks at Computex 2026, where it will showcase AI infrastructure connectivity products including the Scorpio X-Series 320 Lane Smart Fabric Switch, optical connectivity, and COSMOS-enabled validation tools. The event could increase visibility with analysts, customers, and ecosystem partners. Article Title
• Positive Sentiment: Recent coverage highlighted ALAB’s sharp momentum and noted bullish analyst views, reinforcing optimism around Astera Labs’ role in AI networking and semiconductor infrastructure. Article Title
• Positive Sentiment: The company’s recent earnings report was strong, with revenue up 93.5% year over year and EPS beating estimates, while guidance also pointed to continued growth. This supports the rally in ALAB shares.
• Neutral Sentiment: Astera Labs presented at TD Cowen’s Technology, Media & Telecom conference, but the transcript does not appear to include a major new catalyst that would materially change the near-term outlook.
• Negative Sentiment: Insider selling remains a concern: General Counsel Philip Mazzara sold 796 shares, and COO Sanjay Gajendra sold 400,000 shares under a pre-arranged trading plan. While not necessarily a fundamental red flag, heavy insider sales can pressure sentiment after a big run-up. Article Title
• Negative Sentiment: Northland Securities downgraded Astera Labs from outperform to market perform, which may limit upside enthusiasm in the short term.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Jefferies Financial Group reiterated a "buy" rating and issued a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. TD Cowen upped their target price on Astera Labs from $140.00 to $225.00 and gave the stock a "hold" rating in a report on Wednesday, May 6th. Loop Capital assumed coverage on Astera Labs in a report on Thursday, March 5th. They issued a "buy" rating and a $250.00 target price for the company. Royal Bank Of Canada upped their target price on Astera Labs from $250.00 to $270.00 and gave the stock an "outperform" rating in a report on Wednesday, May 6th. Finally, Roth Mkm reiterated a "buy" rating and issued a $275.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $233.75.

Astera Labs Trading Up 2.1%

The stock has a market capitalization of $55.76 billion, a P/E ratio of 219.82, a price-to-earnings-growth ratio of 4.06 and a beta of 3.35. The company has a 50-day moving average price of $178.09 and a 200 day moving average price of $161.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business's revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the company's stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company's stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the company's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,316,257 shares of company stock valued at $474,860,636 in the last ninety days. Corporate insiders own 12.50% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ALAB. Atreides Management LP increased its position in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Vanguard Group Inc. increased its position in Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock valued at $2,690,907,000 after buying an additional 1,693,918 shares in the last quarter. Amundi increased its position in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company's stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC acquired a new position in Astera Labs during the 3rd quarter valued at about $209,599,000. Finally, BNP Paribas Financial Markets increased its position in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company's stock valued at $220,733,000 after buying an additional 960,899 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.